AMP-Activated Protein Kinase and Type 2 Diabetes

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|13|5|583-589

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.5, 2006-03, pp. : 583-589

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the AMP-Activated Protein Kinase for the Treatment of Type 2 Diabetes

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 2, Iss. 2, 2002-07 ,pp. : 119-127

Bentham Science Publishers

Access to resources Recommend Favorite

Prolonged AMP-activated protein kinase induction impairs vascular functions

By Ertuna Elif  

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 12, 2013-01 ,pp. : 1025-1030

NRC Research Press

Access to resources Recommend Favorite

AMP-activated protein kinase — the fat controller of the energy railroad

By Steinberg Gregory R.   Macaulay S. L.   Febbraio Mark A   Kemp Bruce E.  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 7, 2006-07 ,pp. : 655-665

NRC Research Press

Access to resources Recommend Favorite

Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation

By Salt Ian P   Palmer Timothy M  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 8, 2012-08 ,pp. : 1155-1167

Informa Healthcare

Access to resources Recommend Favorite

AMP-activated protein kinase modulators: a patent review (2006 –– 2010)

By Yun Hee   Ha Joohun  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 7, 2011-07 ,pp. : 983-1005

Informa Healthcare

Access to resources Recommend Favorite